Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: MarketLine (a Datamonitor Company)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ildong Pharmaceutical Co., Ltd. to Divest Pharmaceutical Business into Subsidiary

Monday, 14 Oct 2013 02:22am EDT 

Ildong Pharmaceutical Co., Ltd. announced that it has decided to divest its pharmaceutical business into a newly established wholly owned subsidiary, and the remaining part of the Company will be engaged in the operation of investment business. The division ratio of the new entity of the Company is 0.7470193 : 0.2529807. The transaction effective date and registration date are expected to be March 1, 2014 and March 4, 2014, respectively. The new entity will also apply for listing on Korea Exchange. 

Company Quote

50.0 +0.36%
22 Aug 2014